These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 6201891)

  • 1. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 2. Conclusion: is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis?
    Alvord EC
    Prog Clin Biol Res; 1984; 146():503-8. PubMed ID: 6201920
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination.
    Raine CS
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521
    [No Abstract]   [Full Text] [Related]  

  • 4. The nature of factors in chronic relapsing EAE and MS sera which induce myelinotoxicity and cellular changes in organ culture.
    Bradbury K; Suckling AJ
    Prog Clin Biol Res; 1984; 146():193-8. PubMed ID: 6201890
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of myelin lipids in experimental allergic encephalomyelitis.
    Hosein ZZ; Gilbert JJ; Strejan GH
    Prog Clin Biol Res; 1984; 146():49-54. PubMed ID: 6201918
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
    Genain CP; Cannella B; Hauser SL; Raine CS
    Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and humoral immune response to MBP during the course of chronic relapsing EAE.
    Schwerer B; Schuller-Levis GB; Mehta PD; Madrid RE; Wisniewski HM
    Prog Clin Biol Res; 1984; 146():187-92. PubMed ID: 6201889
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin-binding antibodies in vitro. Immunoperoxidase studies with experimental allergic encephalomyelitis, anti-galactocerebroside and multiple sclerosis sera.
    Johnson AB; Bornstein MB
    Brain Res; 1978 Dec; 159(1):173-82. PubMed ID: 83176
    [No Abstract]   [Full Text] [Related]  

  • 10. Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis (1,2).
    Paterson PY; Day ED
    Clin Immunol Rev; 1981-1982; 1(4):581-697. PubMed ID: 6188568
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental allergic encephalomyelitis and neuritis: immunologic responses to myelin basic proteins.
    Brostoff SW
    Birth Defects Orig Artic Ser; 1978; 14(5):245-60. PubMed ID: 687794
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental autoimmune demyelinating diseases: experimental allergic encephalomyelitis and experimental allergic neuritis.
    Lisak RP; Behan PO
    Biomedicine; 1975 Mar; 22(2):81-7. PubMed ID: 55276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neuroglial and anti-neuronal cell factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Bornstein MB
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:574-607. PubMed ID: 4906733
    [No Abstract]   [Full Text] [Related]  

  • 14. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
    Raine CS
    Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
    [No Abstract]   [Full Text] [Related]  

  • 15. Further studies of the allergic nature of multiple sclerosis and the commencement of therapeutic trials.
    Campbell B; Vogel PJ; Fisher E; Lorenz R
    Trans Am Neurol Assoc; 1970; 95():192-5. PubMed ID: 5514365
    [No Abstract]   [Full Text] [Related]  

  • 16. Myelin basic protein, a specific protein of the central nervous system.
    Karcher D
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():85-7. PubMed ID: 6202352
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenetic aspects of demyelinating lesions in chronic relapsing experimental allergic encephalomyelitis: possible interaction of cellular and humoral immune mechanisms.
    Lassmann H; Schwerer B; Kitz K; Egghart M; Bernheimer H
    Prog Brain Res; 1983; 59():305-15. PubMed ID: 6198681
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem.
    Paterson PY; Fujinami RS; Day ED; Varitek VA; Pescovitz MD; Kelly J; Lorand L
    Trans Am Clin Climatol Assoc; 1978; 89():109-18. PubMed ID: 81557
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibodies in the pathogenesis of demyelination in chronic relapsing EAE (cr-EAE).
    Lassmann H; Suchanek G; Kitz K; Stemberger H; Schwerer B; Bernheimer H
    Prog Clin Biol Res; 1984; 146():165-70. PubMed ID: 6718423
    [No Abstract]   [Full Text] [Related]  

  • 20. Myelin peptides in multiple sclerosis.
    Grau-López L; Raïch D; Ramo-Tello C; Naranjo-Gómez M; Dàvalos A; Pujol-Borrell R; Borràs FE; Martínez-Cáceres E
    Autoimmun Rev; 2009 Jul; 8(8):650-3. PubMed ID: 19393199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.